DAILIES TOTAL1® Soft Contact Lenses - Post-Market Clinical Follow-up Study
NCT ID: NCT06483113
Last Updated: 2025-07-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
192 participants
OBSERVATIONAL
2024-11-26
2025-02-27
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Assessment of a Daily Disposable Soft Silicone Hydrogel Contact Lens
NCT06044948
Post-market Clinical Follow-up Study of Alcon TOTAL30® Contact Lenses (Lehfilcon A)
NCT06408649
Surface Refractive Index Shift and Lens Absorption/Adsorption of Tear Components of Kalifilcon A Lenses vs Dailies Total1 and Precision1
NCT04840563
Clinical Assessment of DAILIES TOTAL1® (DT1) Multifocal
NCT02871375
Prospective Study of an Investigational Toric Soft Contact Lens
NCT01461811
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The Baseline visit is defined as the first office visit where an eye care professional provided an in-person office biomicroscopy exam to the subject before or during which a DAILIES TOTAL1 sphere, toric, or multifocal soft contact lens prescription was released. The Baseline visit will be retrospective. All assessments at baseline will be obtained from chart reviews.
The Year 1 visit is defined as the visit that occurs 1 year (-2/+4 months) since the Baseline visit during which period the subject is wearing prescribed lenses and a contact lens examination is performed. The Year 1 visit can be either retrospective or prospective in subjects 7 to less than 18 years of age. For subjects 18 years of age and older, the Year 1 visit will be retrospective.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
DAILIES TOTAL1 Sphere
Delefilcon A spherical soft contact lenses worn in both eyes in a real-world setting
Delefilcon A spherical soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)
DAILIES TOTAL1 Toric
Delefilcon A toric soft contact lenses worn in both eyes in a real-world setting
Delefilcon A toric soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism
DAILIES TOTAL1 Multifocal
Delefilcon A multifocal soft contact lenses worn in both eyes in a real-world setting
Delefilcon A multifocal soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with presbyopia
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Delefilcon A spherical soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia)
Delefilcon A toric soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with astigmatism
Delefilcon A multifocal soft contact lenses
Silicone hydrogel contact lenses prescribed for single use, daily disposable wear (less than 24 hours while awake) for the correction of ametropia (myopia or hyperopia) with presbyopia
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Wearers of delefilcon A (sphere, toric, or multifocal) soft contact lenses of the same design in both eyes who have already begun use of the lens type and have purchased at least 3-month supply of lenses at baseline.
* Best corrected distance visual acuity (BCVA) 20/25 or better in each eye at baseline.
Exclusion Criteria
* Use of systemic or ocular medications that would contraindicate contact lens wear at baseline.
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Alcon Research
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Trial Lead, Vision Care
Role: STUDY_DIRECTOR
Alcon Research, LLC
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Westview Optometry
San Diego, California, United States
Scripps Optometric Group
San Diego, California, United States
Dr. Walker and Associates
Ponte Vedra Beach, Florida, United States
Advanced Eyecare Specialists
West Palm Beach, Florida, United States
The Eye Doctors Inc
Eden Prairie, Minnesota, United States
Cornea and Contact Lens Institute of Minnesota
Edina, Minnesota, United States
Complete Eye Care of Medina
Medina, Minnesota, United States
Koetting Associates
St Louis, Missouri, United States
Center for Ophthalmic and Vision Research
New York, New York, United States
Optometry Group, PLLC
Memphis, Tennessee, United States
Southern Utah Medical Research
St. George, Utah, United States
Spokane Eye Clinic
Spokane, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CLU484-N001
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.